Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05309330 · ClinicalTrials.gov registry record
Virtual Celiac Symptoms Study in Adults and Teenagers
A clinical trial, sponsored by Takeda.
- Completed
- Registry status
- 480
- Enrollment target
NCT05309330: Completed study, sponsored by Takeda.
NCT05309330 is a clinical trial that has completed, run by Takeda. The registered enrollment target is 480 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05309330 has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- 480 participants
- Enrollment target
Study Summary
The goal of this study is to better understand the symptoms and impacts of celiac disease (CeD). Participants use a smart phone online app to answer daily questionnaires about symptoms and life with CeD for 12 weeks. There are no blood draws, gluten challenges, medications, or doctor visits required.
Primary Outcome
The CDSD is a celiac specific symptom assessment tool administered daily. The symptoms measured will include diarrhea, abdominal pain, bloating, nausea/vomiting, number of bowel movements and tiredness. Presence and count of each symptom will be reported for the overall sample as well as separately for adults (age greater than or equal to \[\>=\] 18) and adolescents (age \>=12 less than \[\<\] 18).
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2022-08-16 |
| Est. Completion | 2023-03-04 |
What the finished NCT05309330 record still lists
NCT05309330 is an observational study that tracks outcomes without assigning an intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT05309330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05309330 about?
NCT05309330 is a clinical study titled "Virtual Celiac Symptoms Study in Adults and Teenagers". The goal of this study is to better understand the symptoms and impacts of celiac disease (CeD). Participants use a smart phone online app to answer daily questionnaires about symptoms and life with CeD for 12 weeks. There are no blood draws, gluten challenges, medications, or doctor visits required...
What is the current status of trial NCT05309330?
This trial is currently completed. The enrollment target is 480 participants. The study started on 2022-08-16. Estimated completion is 2023-03-04.
What interventions are being tested in trial NCT05309330?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT05309330?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI